Introduction
Leading pharmaceutical manufacturer commenced commercial production of a high-potent anaesthetic API at its Tanuku facility, with additional high-value APIs planned for FY27 revenue growth.
Also Read: Coforge gains 3% after partnering with Innovaccer to accelerate AI adoption in healthcare
Share price movement of Wanbury
On January 28, 2026, Wanbury Ltd opened at ₹166.15, up 1.88% from its previous close of ₹163.10. The stock reached a high of ₹182.80 (12.05%) and a low of ₹162.75. By 2:29 PM, it traded at ₹174.00, a 6.68% increase, with a market cap of ₹607.12 crore.
Wanbury Starts API Production
Wanbury Limited announced commercial production of a high-potent anaesthetic API at its Tanuku, Andhra Pradesh facility, targeting revenue contribution beginning Q4 FY26 and expansion in FY27 for domestic global markets.
The new API is expected to generate about Rs 18 crore revenue in Q4 FY26, strengthening Wanbury’s API portfolio and near-term earnings outlook from commercial production at Tanuku facility site.
Wanbury said a multipurpose intermediate block at Tanuku will be ready by March 2026, enabling four additional APIs and projected over Rs 100 crore revenue in FY27 from global demand.
Stock performance of Wanbury for Period of 1 week, 6 months, and 1 year
Wanbury Ltd delivered a -9.38% return over the past week, declined 39.2% in the past 6 months, and fell 25.6% over the past 1 year.
Also Read: Airfloa Rail zooms 4% after signing MoU with Janatics for automatic train doors
Shareholding pattern of Wanbury
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 |
| Promoter | 43% | 39.60% | 39.60% |
| FII | 0.70% | 0.80% | 1.60% |
| DII | 0.00% | 0.00% | 0.00% |
| Public | 56.20% | 59.60% | 58.80% |
About Wanbury
Wanbury Ltd (NSE: WANBURY), founded in 1988, is a pharmaceutical company specializing in global API sales, domestic branded formulations, and research, with presence in over 50 countries.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
Q: Why is Wanbury Ltd share price rising today?
A: Wanbury Limited starts commercial production of anaesthetic API at Tanuku facility, expects Rs 18 crore revenue in Q4 FY26 and additional APIs by March 2026.
Q: What is Wanbury Ltd’s main business focus?
A: Wanbury Ltd focuses on pharmaceutical products, including global API sales, domestic branded formulations, and research with presence in over 50 countries.
Q: What is the 52-week high and low of Wanbury Ltd stock?
A: Wanbury Ltd stock has a 52-week high of Rs 330.00 and a 52-week low of Rs 155.00.


